Showing 1,981 - 2,000 results of 4,762 for search '(( significant decrease decrease ) OR ( significantly observed decrease ))~', query time: 0.29s Refine Results
  1. 1981

    Calibration curve. by Feng Zhang (6548)

    Published 2025
    “…</p><p>Results</p><p>After PSM, each group consisted of 55 patients. The observation group showed significantly lower levels of white blood cell count (WBC), neutrophil count (NEUT), lymphocyte count (LYM), red blood cell count (RBC), hemoglobin (HGB), and albumin (ALB) compared to the control group (P < 0.05). …”
  2. 1982

    Decision curves. by Feng Zhang (6548)

    Published 2025
    “…</p><p>Results</p><p>After PSM, each group consisted of 55 patients. The observation group showed significantly lower levels of white blood cell count (WBC), neutrophil count (NEUT), lymphocyte count (LYM), red blood cell count (RBC), hemoglobin (HGB), and albumin (ALB) compared to the control group (P < 0.05). …”
  3. 1983
  4. 1984

    VCC monomer and pre-formed oligomer induce pro-inflammatory responses in the BMDCs. by Shraddha Gandhi (21001590)

    Published 2025
    “…Bar graphs represent the averages (of �ll viability) ± SDs from three independent treatments. **, p < 0.01; ***, p < 0.001; one-way ANOVA with Dunnett’s multiple comparison test. (C-E) Significant productions of IL-6 (C), TNF-α (D), and IL-1β (E) were observed in BMDCs upon treatment with VCC monomer and pre-formed VCC oligomer. …”
  5. 1985
  6. 1986

    Characterisation of conidial length and ascospore production in <i>ΔFgknr4</i> and complemented strains. by Erika Kroll (20537020)

    Published 2025
    “…<p><b>A.</b> Decreased conidial length observed in <i>ΔFgknr4</i>. …”
  7. 1987

    Crystal violet assay. by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  8. 1988

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  9. 1989

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  10. 1990

    FCM analysis (%). by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  11. 1991

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  12. 1992

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  13. 1993

    ESR Data for by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  14. 1994

    Experiments (Crystal violet assay). by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  15. 1995
  16. 1996

    Live/Dead cells 4 days incubation. by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  17. 1997

    ESR Fig 4, Table 1 data. by Takanori Kitagawa (20727226)

    Published 2025
    “…The observation suggests the presence of a diffusible factor against cell proliferation in YCW-H, a phenomenon not observed in the presence of untreated YCW. …”
  18. 1998

    Description of study characteristics. by Feline de la Court (15194678)

    Published 2025
    “…Loss of PrEP retention rates were significantly (p < 0.05) lower in studies from Europe, Australia and multiple regions (vs. …”
  19. 1999

    Data (NICU - AMR Data set). by Biniyam Tedla Mamo (20598461)

    Published 2025
    “…More than half neonatal sepsis was caused by MDR organisms and associated with significant poor treatment outcomes. high prevalence of MDR-gram-negative bacteremia is alarming and highlights the need for the implementation of routine surveillance and infection control measures to decrease morbidity and mortality and to combat the development of antimicrobial resistance.…”
  20. 2000

    Patient characteristic. by Biniyam Tedla Mamo (20598461)

    Published 2025
    “…More than half neonatal sepsis was caused by MDR organisms and associated with significant poor treatment outcomes. high prevalence of MDR-gram-negative bacteremia is alarming and highlights the need for the implementation of routine surveillance and infection control measures to decrease morbidity and mortality and to combat the development of antimicrobial resistance.…”